XML 210 R92.htm IDEA: XBRL DOCUMENT v3.24.3
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Nov. 06, 2024
Mar. 21, 2024
Jul. 30, 2024
Jul. 19, 2024
Jun. 27, 2024
Jan. 23, 2024
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Apr. 22, 2024
Common stock share sold             901,488        
Gross proceeds from share sold             $ 649,039 $ 9,950,037 $ 10,000,017 $ 35,275,573  
Common stock, par value             $ 0.001   $ 0.001 $ 0.001  
Subsequent Events [Member]                      
Purchase price for the acquisition amounted           $ 637,080,000,000          
Consideration share           280,000          
Fair value of shares           $ 319,200          
Settelment amount           317,880          
Intangible asset           $ 637,080          
Common stock share sold   901,488                  
Gross proceeds from share sold   $ 648,893                  
Common stock, par value                     $ 0.001
Bid price the closing bid price of the Company’s common stock being at least $1.00 per share for ten consecutive business days                    
Minimum bid price $ 1.00                    
Deadline report     Nasdaq further extended the filing deadline through October 14, 2024                
Closing bid of shares of common stock $ 1.00                    
Subsequent Events [Member] | Pharmalink [Member]                      
First purchase order         130,000            
First year purchase order         500,000            
Over year five purchase order         3,000,000            
Subsequent Events [Member] | Notification Letter [Member]                      
Bid price       closing bid price of $1.00 or greater per common share for ten consecutive business days from July 5, 2024 to July 18, 2024              
Minimum bid price       $ 1.00              
Subsequent Events [Member] | Placement Agent [Member]                      
Fees and other commissions   23,153                  
Net proceeds   $ 625,740